#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian cancer stage IV Squamous cell carcinoma of head and neck Spinal muscular atrophy Richter's syndrome Ovarian cancer Hypereosinophilic syndrome Choroid melanoma Adrenogenital syndrome Hyperinsulinism Sickle cell disease Mitochondrial encephalomyopathy Mantle cell lymphoma stage IV Cervix carcinoma Immune thrombocytopenia Hyperchylomicronaemia More trials…

    Learn about Rare Diseases

    Lennox-Gastaut syndrome – Treatment Hereditary neuropathic amyloidosis – Trials in Disease Cholangitis sclerosing – Diagnostics Breast angiosarcoma metastatic – Trials in Disease Idiopathic inflammatory myopathy – Diagnostics Ewing’s sarcoma metastatic – Trials in Disease Hyperoxaluria – Treatment Breast angiosarcoma metastatic – Treatment Erdheim-Chester disease – Diagnostics Atypical haemolytic uraemic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bidridistrogene Xeboparvovec Thiamine Hydrochloride AVTX-009 Mebeverine Hydrochloride Octreotide Hydrochloride Pyrazinamide COLESEVELAM HYDROCHLORIDE L-Histidine Hydrochloride Ly3871801 Letrozole Allo-501A Acetylcysteine Amide Loratadine Romiplostim Roxadustat Levamisole Hydrochloride Phleum Pratense (225) Mometasone Furoate Monohydrate Chlorphenamine Maleate Perflutren More therapies…

    Learn about Your Condition

    Brain neoplasm malignant Macular telangiectasia Malignant glioma Antithrombin III deficiency Herpes simplex meningitis Cancer pain Niemann-Pick disease Haemodialysis Arterial disorder Mitral valve incompetence Pancoast's tumour Rhabdoid tumour of the kidney Glomerulonephritis acute Hepatic adenoma Anal cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Staedtisches Klinikum Goerlitz gGmbH

Staedtisches Klinikum Goerlitz gGmbH

Girbigsdorfer Strasse 1-3, Innenstadt, Goerlitz, 02828, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Bulgaria Czechia Denmark France Germany Greece +8
  • Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

    Recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!